Frontiers in Immunology (Sep 2023)

CircUBXN7 promotes macrophage infiltration and renal fibrosis associated with the IGF2BP2-dependent SP1 mRNA stability in diabetic kidney disease

  • Ziyue Lin,
  • Ziyue Lin,
  • Dan Lv,
  • Dan Lv,
  • Xiaohui Liao,
  • Rui Peng,
  • Handeng Liu,
  • Tianhui Wu,
  • Keqian Wu,
  • Yan Sun,
  • Yan Sun,
  • Zheng Zhang,
  • Zheng Zhang

DOI
https://doi.org/10.3389/fimmu.2023.1226962
Journal volume & issue
Vol. 14

Abstract

Read online

IntroductionInflammatory cell infiltration is a novel hallmark of diabetic kidney disease (DKD), in part, by activated macrophages. Macrophage-to-tubular epithelial cell communication may play an important role in renal fibrosis. Circular RNAs (circRNAs) have been reported in the pathogenesis of various human diseases involving macrophages activation, including DKD. However, the exact mechanism of circRNAs in macrophage infiltration and renal fibrosis of DKD remains obscure.MethodsIn our study, a novel circRNA circUBXN7 was identified in DKD patients using microarray. The function of circUBXN7 in vitro and in vivo was investigated by qRT-PCR, western blot, and immunofluorescence. Finally, a dual-luciferase reporter assay, ChIP, RNA pull-down, RNA immunoprecipitation and rescue experiments were performed to investigate the mechanism of circUBXN7.ResultsWe demonstrated that the expression of circUBXN7 was significantly upregulated in the plasma of DKD patients and correlated with renal function, which might serve as an independent biomarker for DKD patients. According to investigations, ectopic expression of circUBXN7 promoted macrophage activation, EMT and fibrosis in vitro, and increased macrophage infiltration, EMT, fibrosis and proteinuria in vivo. Mechanistically, circUBXN7 was transcriptionally upregulated by transcription factor SP1 and could reciprocally promote SP1 mRNA stability and activation via directly binding to the m6A-reader IGF2BP2 in DKD.ConclusionCircUBXN7 is highly expressed in DKD patients may provide the potential biomarker and therapeutic target for DKD.

Keywords